March 2, 2026

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: An 84.90% Revenue Surge and 37.27% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering entity in RNA interference therapeutics, has been generating buzz in the biotechnology sector with its impressive revenue growth and significant upside potential. Based..

Penumbra, Inc. (PEN) Stock Analysis: Unveiling the Potential in Medical Devices with a 4.57% Upside

Penumbra, Inc. (PEN), a prominent player in the healthcare sector, stands at the forefront of medical device innovation. With a market capitalization of $13.51 billion, Penumbra specializes in developing and..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 34.15% Upside Potential in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $34.41 billion, Agilent is..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A 12.36% Upside Beckons in Healthcare Innovation

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector, has long stood at the forefront of the drug manufacturing industry, particularly specializing in generic and specialty medicines...

Hologic, Inc. (HOLX) Stock Analysis: Navigating Growth in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX) stands at the forefront of the healthcare sector, specializing in medical instruments and supplies with a primary focus on women’s health. With a market cap of..

AptarGroup, Inc. (ATR) Stock Analysis: An Investor’s Guide to a 12% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a leading player in the medical instruments and supplies industry, presents a compelling investment opportunity with a potential upside of 12.33%, as suggested by analyst ratings...

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 2.09% Dividend Yield Amid Market Dynamics

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, stands as a stalwart among drug manufacturers in the United States. With a staggering market capitalization of $598.69 billion,..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Exploring a 42.84% Potential Upside Amidst Robust Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is making waves in the biotechnology sector, attracting the attention of individual investors with its promising outlook and notable growth metrics. With a market capitalization..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Potential 27.89% Upside Amid Robust Growth and Strategic Positioning

As investors navigate the complex landscape of the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) stands out as a formidable player within the diagnostics and research industry. With a..

United Therapeutics (UTHR): Investor Outlook with a 13% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) remains a compelling focus for investors in the healthcare sector, particularly those interested in the specialty and generic drug manufacturing industry. With a market capitalization..

Tenet Healthcare Corporation (THC) Stock Analysis: A Strong Buy with 7.36% Potential Upside

Tenet Healthcare Corporation (NYSE: THC) stands as a prominent player in the U.S. healthcare sector, showcasing impressive growth and robust market positioning. With a market capitalization of $21.04 billion, Tenet..

Stryker Corporation (SYK) Stock Analysis: A Healthcare Giant with Promising Upside Potential

Stryker Corporation (NYSE: SYK), a heavyweight in the healthcare sector, is widely recognized for its innovative contributions to medical devices. With a robust market capitalization of $148.28 billion, Stryker stands..

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Promising 25% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) offers a compelling opportunity for investors looking to capitalize on the robust growth and innovation in the healthcare sector. Specializing in the design and..

Solventum Corporation (SOLV) Stock Analysis: A 21% Upside Potential Amidst Mixed Signals

Investors seeking opportunities in the healthcare sector may find Solventum Corporation (NYSE: SOLV) an intriguing prospect. This Maplewood, Minnesota-based company, with a market cap of $12.87 billion, operates in the..

Baxter International Inc. (BAX) Stock Analysis: Navigating Opportunities with a 6.20% Potential Upside

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently at a pivotal point for investors seeking value amidst fluctuating market conditions. With a market capitalization..

Boston Scientific Corporation (BSX) Stock Analysis: With a 36.3% Potential Upside, Is It Time to Invest?

Boston Scientific Corporation (NYSE: BSX), a leading player in the medical devices sector, is capturing investor interest with its robust growth metrics and promising analyst ratings. As of the latest..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with 8.50% Upside Potential

In the ever-evolving landscape of healthcare, Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, presents itself as a formidable contender in the medical distribution industry. With a robust market..

Cardinal Health, Inc. (CAH) Investor Outlook: Strong Growth Potential with 8.54% Upside

Cardinal Health, Inc. (NYSE: CAH) is making headlines in the healthcare sector as a formidable player in medical distribution. With a market capitalization of $53.94 billion, this Dublin, Ohio-based company..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Growth with a Potential 4.28% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a notable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $19.51 billion, Zimmer Biomet..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 9.86% Upside in the Diagnostics & Research Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a leader in precision instruments and services, stands out in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Greifensee, Switzerland, the..

Search

Funds

March 2, 2026

Search

Funds

March 2, 2026

FTSE 100

Funds